Answers Logo
Search


A recently published study in the New England Journal of Medicine concluded that post-marketing safety concerns were more likely for medicines approved by the



Seems plausible given the pressure the agency is under for speedy review times.

Hogwash. The study’s methodology was wrong.

Interesting statistics, but not enough to make a sound determination.

This is precisely the problem with user-fee mandated deadlines.

Vote

Share/Save/Bookmark
View The Results of This Poll




rss

User

This user does not have a PollDaddy profile set up yet...

View My Previous Polls

Share Link

Use the link below to share this poll.

Embed This Poll

You can also place this poll on your website or blog as a widget. Simply copy and paste the code below into your HTML.

Alternatively, we now support oEmbed.